Today is Wednesday, Aug. 12, 2020

Department of

Surgery

Transplant Research Virtual Symposium

Click the link below to join the meeting on June 26.

Join WebEx meeting June 26

Time Title Presenter
9-9:10 Introduction  
9:10-9:30 UC Health Mini (poster) presentation: Evaluation of a Surveillance after Prophylaxis Strategy for Cytomegalovirus Prevention in Liver Transplant Recipients           Parrish, Luckett
9:30- 10:10 Carfilzomib-Based Desensitization: Effects on HLA, Non-HLA, Auto, and Antiviral Antibodies Tremblay, Woodle
9:30- 10:10 BAFF Inhibition to Prevent Antibody Rebound Following Proteasome Inhibitor-Based Desensitization: A Randomized, Controlled Trial  Tremblay, Woodle
11:10-10:30 Belatacept Removal by Plasmapheresis: Kinetics, Dose Adjustments and Clinical Recommendations          Tremblay, Vinks
10:30-12:10 Analysis of Rejection, Rejection Therapy and Renal Function in the BEST Trial        Kuzaro, Woodle
10:30-12:10 Patient-Reported Outcomes in a Prospective Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression Regimens in Kidney Transplantation: A Prospective Analysis Across Two Years Rohan, Alloway
10:30-12:10 A Prospective Randomized Multicenter Trial (BEST Trial) of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression: Infectious Complications           West-Thielke, Woodle
10:30-12:10 Belatacept-Based, Calcineurin Inhibitor and Corticosteroid Free Immunosuppression: Differential Outcomes Based on Recipient Age    Wilson, Woodle
10:30-12:10 Belatacept-Based Regimens: Induction and Recipient Gender Influence Outcomes                Wilson, Woodle
12:10-12:30 Belatacept Based Early Steroid Withdrawal Regimens: Differential Responses in African Americans and Non-African Americans   Wilson, Woodle
12:10-12:30 Comparison of Reduced-Dose and Labeled-Dose Belatacept Conversion with Immediate or Early Tacrolimus Withdrawal in Kidney Transplant Recipients without Maintenance Corticosteroids Kuzaro, Kremer
12:30-12:45 Bone Marrow Plasma Cell Heterogeneity Drives Resistance of Proteasome Inhibitor Therapy Cyd Castro Rojas
12:45-12:55 Allotransplantation of Ligated Arteriovenous Fistula as a Novel Strategy for Patients with Multiple Vascular Access Failures              Jaramillo-Gante, Linares-Cervantes
12:55-1:15 Feasibilty of Hepatitis C NAT Positive Kidney Transplant into Hepatitis C Negative Recipients as Standard of Care              Kaur, Govil
1:15-1:55 Other Renal Mini (poster) presentation:  
1:15-1:55 A Single Center Experience of Atypical Hemolytic Uremic Syndrome Post Solid Organ Transplantation - "Benign Genetic Variants: Perhaps No More" Khan, Abu Jawdeh
1:15-1:55 Outreach as a Way to Improve Access to Kidney Transplants: A Model to Align with Future of Kidney Disease Care        Govil, Thakar
1:15-1:55 Racial Disparities in Long-Term Outcomes in Kidney Transplantation from Elderly Donors in United States     Silvi Shah, Jain
1:15-1:55 The Role of Complement-Split Products as Biomarkers for Acute Antibody-Mediated Rejection of Kidney Allografts         Abu Jawdeh, Dixon
1:55-2:15 "Liver: No Kidney after Liver Left Behind: An Analysis of the Organ Procurement and Transplantation Network "Safety Net" Policy" Lee, Quillin
2:15-2:25 Liver Mini (poster) presentation: Sparing the Nephron in Liver Transplant Recipients with Antithymocyte Bridging: A Four Year Experience Wilson, Kaiser
2:25-2:45 Education: Transplant Surgery Continuing Professional Development Courses Increase Knowledge and Procedural Confidence Hobeika, Diwan
2:45-2:55 Education Mini (poster) presentation: Organ Offer Behavioral Research Enhances Transplant Surgeon Training  Diwan, Ratner
2:55-3:00 Conclusion
Surgical researchers in the UC Department of Surgery.
More Information:
Alex B. Lentsch, PhD
Program Director
Department of Surgery
University of Cincinnati College of Medicine
231 Albert Sabin Way
Cincinnati, OH 45267-0558
513-558-8674

Alex.Lentsch@uc.edu